Optimer Biotechnology, Inc. (OBI) is a biotech company was formed in Taiwan in 2002. At beginning, it’s structured as a wholly owned subsidiary of Optimer Pharmaceuticals Inc. (OPTR) in San Diego, CA, USA. In November, 2009, it was spinning off from OPTR, forming a new management team with a mission to develop novel therapeutic agents for diseases that are currently lacking treatment options. The initial therapeutic focus will be cancer and osteoarthritis. OBI is positioned as a new product development company striving to improve health and quality of life through innovative and cost effective medicine.
Headquarters
6F., No. 508, Sec. 7, Zhongxiao E. Rd, Nangang Dist
Taipei City; Taipei City;
Contact Details: Purchase the OBI Pharma, Inc. report to view the information.
Website: http://www.obipharma.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service